Skip to content

Interferential Current and Transcutaneous Electrical Nerve Stimulation for Pain After Cesarean Section

Comparison of the Effects of Interferential Current and Transcutaneous Electrical Nerve Stimulation on Pain Following Cesarean Section

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07847502
Acronym
IC-TENS-CS
Enrollment
54
Registered
2026-09-29
Start date
2026-03-04
Completion date
2027-02-01
Last updated
2026-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Pain After Cesarean Section

Keywords

Transcutaneous Electrical Nerve Stimulation, TENS, Interferential Current Therapy, Cesarean Delivery, Postpartum Comfort, Acute Postoperative Pain, Nonpharmacological Pain Management

Brief summary

This study aims to compare the immediate and short-term effects of interferential current therapy and conventional transcutaneous electrical nerve stimulation (TENS) with placebo stimulation on pain and postpartum comfort following cesarean section. A total of 54 primiparous women aged 18-40 years will be randomly assigned to an interferential current, TENS, or placebo group. Each intervention will be administered for 30 minutes. Pain intensity at rest and during in-bed activities will be assessed before the intervention, immediately after the intervention, and at 1 and 2 hours after the intervention. Postpartum comfort, treatment satisfaction, anxiety, and depression will also be evaluated.

Detailed description

This is a prospective, randomized, placebo-controlled, three-arm clinical trial conducted in the Obstetrics and Gynecology Department of Menteşe State Hospital. The study will include 54 primiparous women following cesarean section. Eligible participants who provide written informed consent will be randomly allocated to the conventional TENS group, interferential current therapy group, or placebo stimulation group. All interventions will be administered in the supine position with a pillow placed under the knees. Four self-adhesive electrodes will be positioned around the cesarean incision. Conventional TENS will be applied at a frequency of 125 Hz and a pulse duration of 60 microseconds. Interferential current therapy will be applied using a fixed frequency of 100 Hz. In both active intervention groups, current intensity will be increased to a strong but comfortable sensory level and adjusted throughout the session to maintain the same sensation. In the placebo group, the electrodes and device will be applied in the same manner, but no electrical current will be delivered. Each intervention will last 30 minutes. An assessor blinded to group allocation will perform all evaluations. Pain intensity at rest and during in-bed activities will be assessed using separate 0-10 cm visual analog scales before the intervention, immediately after the intervention, and at 1 and 2 hours after the intervention. Postpartum comfort will be evaluated before the intervention and 2 hours after the intervention using the Postpartum Comfort Questionnaire. Treatment satisfaction will be assessed immediately, 1 hour, and 2 hours after the intervention. Baseline anxiety and depression levels will be evaluated using the Hospital Anxiety and Depression Scale.

Interventions

Conventional TENS will be applied for 30 minutes at a frequency of 125 Hz and a pulse duration of 60 microseconds. Four self-adhesive electrodes will be positioned around the cesarean incision. Current intensity will be increased to a strong but comfortable sensory level and adjusted during the session to maintain the same sensation.

Interferential current therapy will be applied for 30 minutes using a fixed frequency of 100 Hz. Four self-adhesive electrodes will be positioned around the cesarean incision in a crossed arrangement. Current intensity will be increased to a strong but comfortable sensory level and adjusted during the session to maintain the same sensation.

The electrodes and stimulation device will be applied in the same position and for the same 30-minute duration as in the active intervention groups; however, no electrical current will be delivered.

Sponsors

Dilara Özen Oruk
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

Participants will not be informed of their treatment allocation. Outcome assessments will be performed by a physiotherapist who is blinded to group allocation. The physiotherapist administering the interventions will not be blinded because the stimulation parameters must be adjusted during treatment.

Intervention model description

Participants will be randomly assigned in a 1:1:1 ratio to the conventional TENS, interferential current therapy, or placebo stimulation group.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* Women aged 18 to 40 years * Ability to read, write, and communicate in Turkish * Primiparous women * Having delivered a healthy singleton infant by cesarean section * No additional surgical procedure or complication during or after the cesarean section

Exclusion criteria

* Impaired orientation or cooperation * History of systemic disorders, including hyperglycemia or hypertension, gastrointestinal disorders, or urogynecological disorders * Previous abdominal surgery * Neurological, orthopedic, cardiopulmonary, or other health conditions that may prevent mobilization or ambulation * Previous experience with transcutaneous electrical nerve stimulation or interferential current therapy * Contraindications to electrical stimulation, including sensory loss at the application site, dermatological problems or allergic reactions at the application site, or a cardiac pacemaker

Design outcomes

Primary

MeasureTime frameDescription
Change in Pain Intensity at RestBaseline, immediately after the 30-minute intervention, 1 hour after the intervention, and 2 hours after the interventionPain intensity at rest will be assessed using a 10-cm Visual Analog Scale ranging from 0 (no pain) to 10 (worst imaginable pain). Higher scores indicate greater pain intensity. Changes from baseline will be compared among the three groups.

Secondary

MeasureTime frameDescription
Change in Postpartum ComfortBaseline and 2 hours after the interventionPostpartum comfort will be assessed using the Postpartum Comfort Questionnaire. The questionnaire contains 34 items covering physical, psychospiritual, and sociocultural comfort. Total scores range from 34 to 170, with higher scores indicating greater postpartum comfort.
Treatment SatisfactionImmediately after the intervention, 1 hour after the intervention, and 2 hours after the interventionTreatment satisfaction will be assessed using a 10-cm Visual Analog Scale ranging from 0 (not satisfied at all) to 10 (very satisfied). Higher scores indicate greater treatment satisfaction.

Countries

Turkey (Türkiye)

Contacts

CONTACTDilara Özen Oruk, PhD
dilaraozen@mu.edu.tr+902522112072
PRINCIPAL_INVESTIGATORDilara Özen Oruk, PhD

Muğla Sıtkı Koçman University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Oct 3, 2026